Corrona

Corrona provides real-world evidence through syndicated registry data and analytics services, helping biopharmaceutical companies demonstrate the significant value and differentiation of their products to clinicians, patients, payers, and regulators. Corrona operates six major autoimmune registries across the USA, Canada, and Japan, collecting data from over 400 participating investigator sites. Corrona’s data are considered the gold standard in observational research and have been used in over 140 peer reviewed manuscripts and 430 abstracts. Corrona has conducted active safety surveillance to support regulatory commitments for 14 new drug approvals, including formal post authorization safety studies.